Severe OHSS - An acceptable price?

Human Reproduction

Volumn 14, Issue 11, 1999, Pages 2687-2688

  Forman, R G ^a  

^a Centre for Reproductive Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHORIONIC GONADOTROPIN; GONADORELIN AGONIST;

DRUG FATALITY; FEMALE; FEMALE INFERTILITY; HUMAN; NOTE; OVARY HYPERSTIMULATION;

EID: 0032728357     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.11.2687     Document Type: Note

References (19)

1. Abramov, Y., Elchalal, U. and Schenker, J.G. (1999) An 'epidemic' of severe ovarian hyperstimulation syndrome: a price we have to pay? Hum. Reprod., 14, 2181-2183.
2. Asch, R.H., Ivery, G., Goldsman, M. et al. (1993) The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum. Reprod., 8, 1015-1020
3. Cochrane Injuries Group Albumin Reviews (1998) Br. Med. J., 317, 235-240.
4. Cohen, J. (1998) How to avoid multiple pregnancies in assisted reproduction. Hum. Reprod., 13 (Suppl.), 197-214.
5. Committee on Safety of Medicines (1999) The safety of human albumin. Curr. Prob. Pharmacovigilance, 25, 11.
6. Edwards, R.G., Lobo, R. and Bouchard, P. (1996) Time to revolutionize ovarian stimulation. Hum. Reprod., 11, 917-919.
7. Fluker, M.R., Hooper, W.M. and Yuzpe, A.A. (1999) Withholding gonadotrophins ('coasting') to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles. Fertil. Steril., 71, 294-301.
8. Forman, R.G., Frydman, R., Egan, D. et al. (1990) Severe hyperstimulation syndrome using agonists of gonadotrophin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fertil. Steril., 53, 502-509.
9. Forman, R., Robinson, J., Egan, D. et al. (1991) Follicular monitoring and outcome of in-vitro fertilisation in gonadotrophin-releasing hormone agonist treated cycles. Fertil. Steril., 55, 567-573.
10. Golan, A., Ron-El, R., Herman, A. et al. (1989) Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv., 44, 430-440.
11. Lee, C., Tummon, I., Martin, J. et al. (1998) Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome? Hum. Reprod., 13, 1157-1158.
12. Navot, D., Bergh, P.A. and Laufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
13. Ndukwe, G., Thornton, S., Fishel, S. et al. (1997) Severe ovarian hyperstimulation syndrome: is it really preventable by prophylactic intravenous albumin? Fertil. Steril., 68, 851-854.
14. Olivennes, F. and Frydman, R. (1998) Friendly IVF: the way of the future? Hum. Reprod., 13., 1121-1124.
15. Serour, G.I., Aboulghar, M., Mansour, R. et al. (1998) Complication of medically-assisted conception in 3,500 cycles. Fertil Steril., 70, 638-642
16. Shalev, E., Giladi, Y., Matilsky, M. and Ben-Ami, M. (1995) Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin: a prospective study. Hum. Reprod., 10, 1373-1376.
17. Sher, G., Zouves, C., Feinman, M. and Maassarani, G. (1995) 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum. Reprod., 10, 3107-3109.
18. Society for Assisted Reproductive Technology/The American Society for Reproductive Medicine (1999) Assisted Reproductive Technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproduction Technology Registry. Fertil. Steril., 71, 798-807.
19. Waldenstrom, U., Kahn, J., Marsk, L. and Nilsson, S. (1999) High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients; a multicentre study. Hum. Reprod., 14, 294-297.